The focus of this GEN Market & Tech Analysis report is to present some of our recent industry tracking of the epigenetics signatures space as a follow-on to the GEN Report on microRNA associations and signatures that we've recently published.
In this report, we do the following:
- Frame our epigenetics publications analysis
- Present a comparison with our published microRNA and long noncoding publication analyses
- Present epigenetics segments that are "accelerating vs. decelerating"
These analyses present a snapshot of biological content analyzed en bloc as a way to visualize segments that are expanding/contracting and where "publications coalesce".
Both text-clustering results and segmentation results show that cancer is a major focus of epigenetics research. Few other diseases have received so much attention in the epigenetics research community. The fact that “other diseases” have received less attention may be a competitive advantage for commercial players to establish unique research and patent positions in a less crowded space. We believe that our epigenetics hotspot analysis is the first to use en bloc technology landscaping methods to understand connections between cancer, putative biomarkers, and epigenetics and can be used to identify niches of opportunity for product vendors and diagnostics/therapeutics developers.
CLICK HERE to download the PDF report.